Dr. Reddy's Laboratories Limited (RDY)

Dr. Reddy's Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	10,181	11,141	11,155	12,302	9,348	9,415
Market Cap Growth	-13.59%	-0.13%	-9.32%	31.60%	-0.71%	-8.08%
Enterprise Value	10,116	11,018	11,097	11,669	8,972	9,322
Last Close Price	11.97	13.77	13.05	14.45	11.15	10.84

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	29.08	24.38	16.86	18.41	17.03	30.32
PS Ratio	2.91	3.11	2.93	3.67	3.12	3.33
PB Ratio	2.49	2.75	2.83	3.65	3.32	3.75
P/TBV Ratio	3.61	4.03	4.24	4.28	3.92	4.50
P/FCF Ratio	45.12	31.25	50.37	35.31	16.14	53.13
P/OCF Ratio	23.34	18.41	20.53	22.56	13.04	25.42

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	2.89	3.08	2.91	3.48	3.00	3.30
EV/EBITDA Ratio	17.49	15.16	10.80	12.31	11.16	14.82
EV/EBIT Ratio	27.20	20.98	13.17	14.89	13.79	19.70
EV/FCF Ratio	44.83	30.91	50.10	33.49	15.50	52.61

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.19	0.20	0.14	0.07	0.06	0.18
Debt / EBITDA Ratio	1.28	1.11	0.53	0.25	0.20	0.71
Debt / FCF Ratio	3.38	2.31	2.47	0.69	0.28	2.52
Net Debt / Equity Ratio	-0.02	-0.03	-0.03	-0.22	-0.21	-0.05
Net Debt / EBITDA Ratio	-0.17	-0.15	-0.13	-0.78	-0.73	-0.22
Net Debt / FCF Ratio	-0.44	-0.31	-0.59	-2.12	-1.02	-0.78
Asset Turnover	0.61	0.63	0.74	0.79	0.80	0.77
Inventory Turnover	2.12	2.15	2.01	2.06	2.14	2.09
Quick Ratio	1.16	1.13	1.16	1.72	1.58	1.24
Current Ratio	1.90	1.80	1.92	2.58	2.38	1.93
Return on Equity (ROE)	8.84%	11.83%	18.53%	21.77%	21.38%	12.96%
Return on Assets (ROA)	4.01%	5.74%	10.22%	11.51%	10.86%	8.04%
Return on Invested Capital (ROIC)	7.46%	10.96%	19.70%	25.19%	21.99%	15.03%
Return on Capital Employed (ROCE)	8.40%	12.00%	19.90%	22.40%	22.60%	18.10%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	3.44%	4.10%	5.93%	5.43%	5.87%	3.30%
FCF Yield	2.22%	3.20%	1.98%	2.83%	6.19%	1.88%
Dividend Yield	0.54%	0.62%	0.72%	0.66%	0.87%	0.73%
Payout Ratio	15.31%	15.54%	11.78%	11.94%	11.05%	17.59%
Buyback Yield / Dilution	0.05%	0.10%	-0.08%	-0.19%	-0.03%	-0.01%
Total Shareholder Return	0.59%	0.72%	0.64%	0.47%	0.84%	0.71%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jul 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error